Skip to main content
SpringerLink
Log in

Trastuzumab emtansine added to Manitoba drug formulary

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Roche. Manitoba Adds KADCYLA(R) to the Provincial Formulary for the Treatment of HER2-Positive Metastatic Breast Cancer. Media Release : 5 Jun 2014. Available from: URL: http://www.roche.com

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trastuzumab emtansine added to Manitoba drug formulary. PharmacoEcon Outcomes News 705, 11 (2014). https://doi.org/10.1007/s40274-014-1334-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1334-9

Search

Navigation